Trials / Conditions / Adult Acute Lymphoblastic Leukemia

Adult Acute Lymphoblastic Leukemia

8 registered clinical trials studyying Adult Acute Lymphoblastic Leukemia.

Status	Trial	Sponsor	Phase
Unknown	Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL NCT03564704	Nanfang Hospital, Southern Medical University	Phase 2 / Phase 3
Active Not Recruiting	Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT02159495	City of Hope Medical Center	Phase 1
Unknown	Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Pa NCT03419494	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	—
Unknown	Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemi NCT02072785	Nanjing Luye Sike Pharmaceutical Co., Ltd.	Phase 3
Completed	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015	Wake Forest University Health Sciences	Phase 1
Completed	Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patient NCT01251575	Fred Hutchinson Cancer Center	Phase 2
Completed	Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leu NCT00537030	Children's Oncology Group	N/A
Unknown	Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblasti NCT00188084	University Hospital, Angers	—